Clinical Trial Update: To Study the Use of Humanized CD25 in Preventing the Relapse of Psoriasis Vulgaris [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating a humanized CD25 therapy to prevent relapse in psoriasis vulgaris.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Humanized CD25

Snippet

Sponsor: Rockefeller University | Conditions: Psoriasis | Phase 1, Phase 2 | Status: COMPLETED